Canada Natural Health Products Regulations: What US Brands Need to Know

Canada is the second-largest supplement market in North America, with retail sales exceeding CAD $5 billion annually. For US supplement brands, it’s geographically adjacent, culturally similar, and English-speaking — which creates the impression that regulatory compliance should be straightforward. It isn’t. Canada’s Natural Health Products Regulations are more demanding than DSHEA in several important ways, and the pre-market licensing requirement is a fundamental difference that catches many US brands off guard.

What Are Natural Health Products in Canada?

Under Canada’s Natural Health Products Regulations (SOR/2003-196), a Natural Health Product (NHP) is a substance sold for use in diagnosing, treating, mitigating, or preventing a disease, disorder, or abnormal physical state; restoring or correcting organic functions; or modifying organic functions.

NHPs include vitamins, minerals, herbal remedies, homeopathic medicines, traditional medicines, probiotics, and amino acids. The category is broader than the US “dietary supplement” category — some products that are drugs in the US are NHPs in Canada, and vice versa.

The Product Licence Requirement

The most significant difference between Canada’s NHP framework and DSHEA is the pre-market licensing requirement. Under the Natural Health Products Regulations, every NHP must have a Product Licence (PL) issued by Health Canada before it can be sold in Canada.

This is not a notification. It is not a self-certification. It is a formal application to Health Canada that requires scientific evidence of safety and efficacy, and Health Canada must approve the application before the product can be marketed.

The Product Licence number — a Natural Product Number (NPN) or Homeopathic Medicine Number (DIN-HM) — must appear on the product label.

What Does a Product Licence Application Require?

A Product Licence application to Health Canada must include:

Product information:

• Product name
• Dosage form (capsule, tablet, liquid, etc.)
• Route of administration
• Recommended use or purpose (the claim)
• Recommended conditions of use (dose, duration, warnings)

Medicinal ingredients:

• Name of each medicinal ingredient
• Quantity per dosage unit
• Source (plant species, plant part, extraction method for botanicals)
• Potency (for standardised extracts)

Non-medicinal ingredients:

• All excipients, fillers, and other non-medicinal components

Evidence of safety and efficacy:

• Evidence supporting the recommended use (the claim)
• Evidence of safety at the recommended dose

The evidence requirements depend on the product category and the claim. Health Canada has published monographs for many common NHP ingredients — if your product and claim match a monograph, you can reference the monograph rather than submitting independent clinical data.

Health Canada Monographs: The Fast Track

Health Canada’s NHP monographs are pre-evaluated evidence documents that specify the acceptable ingredients, doses, claims, and conditions of use for common NHP categories. Using a monograph significantly simplifies the Product Licence application.

Examples of Health Canada monographs:

• Vitamin C: Specifies permitted claims (antioxidant, immune support), dose ranges, and conditions of use
• Echinacea: Specifies permitted claims (helps relieve symptoms of upper respiratory tract infections), dose ranges, and conditions of use
• Melatonin: Specifies permitted claims (helps reset the body’s sleep-wake cycle), dose ranges, and conditions of use

If your product and claim match a monograph, the application is straightforward — you reference the monograph and demonstrate that your product meets its specifications. If your product or claim doesn’t match any monograph, you must submit independent scientific evidence, which is more complex and time-consuming.

How Long Does a Product Licence Take?

Health Canada’s target review timelines are:

• Class I applications (using a monograph, low-risk): 60 days
• Class II applications (using a monograph, moderate complexity): 180 days
• Class III applications (novel ingredients or claims, no monograph): 300 days

In practice, Health Canada’s actual review times have historically exceeded these targets. As of 2024-2025, actual review times for Class I applications are typically 6 to 12 months; Class III applications can take 2 to 3 years.

GMP Requirements for NHPs

NHPs sold in Canada must be manufactured in compliance with Health Canada’s Good Manufacturing Practices for Natural Health Products (Part 3 of the Natural Health Products Regulations). These GMP requirements are more prescriptive than DSHEA’s 21 CFR Part 111 in some areas.

Key GMP requirements:

• Site licence: The manufacturing site must hold a Site Licence issued by Health Canada
• Batch records: Complete batch manufacturing records for every batch
• Testing: Raw material testing, in-process testing, and finished product testing
• Stability testing: Evidence of product stability throughout the shelf life
• Recall procedures: Documented procedures for product recall

For US manufacturers supplying the Canadian market, the manufacturing site must either hold a Canadian Site Licence or the Canadian importer must hold a Site Licence and take responsibility for GMP compliance.

Labeling Requirements for NHPs in Canada

NHP labels must comply with the Natural Health Products Regulations and Health Canada’s labeling guidance. Required label elements:

• Product name
• NPN or DIN-HM number
• Medicinal ingredients (name, quantity, source)
• Non-medicinal ingredients
• Recommended use or purpose (the claim — must match the Product Licence)
• Recommended dose
• Duration of use (if applicable)
• Cautions and warnings
• Known adverse reactions
• Lot number
• Expiry date
• Name and address of the licence holder
• Net quantity

Bilingual labeling (English and French) is required for products sold nationally in Canada. Products sold only in Quebec must have French labels; products sold only in English-speaking provinces may have English-only labels, but bilingual labeling is strongly recommended for national distribution.

Canada vs. EU: Key Differences for Supplement Brands

Aspect	Canada (NHP)	EU (Food Supplement)
Pre-market approval	Yes — Product Licence required	No — notification in some countries
Ingredient lists	Positive approach via monographs	Positive lists for vitamins/minerals
Health claims	Approved via Product Licence	EU Register of authorised claims
GMP	Health Canada NHP GMP + Site Licence	Food safety GMP (ISO 22000)
Labeling language	English + French	Official language(s) of member state
Timeline	6 months to 3 years	2-6 months (for notification)

Practical Strategy for US Brands Entering Canada

For US supplement brands entering Canada, the recommended approach is:

1. Identify your target claims: The claim determines the regulatory pathway. Claims that match Health Canada monographs are significantly faster to license.

2. Assess ingredient compliance: Verify all ingredients are acceptable under Health Canada’s NHP framework. Some US supplement ingredients are not permitted in Canadian NHPs.

3. Apply for Product Licences before entering the market: Unlike DSHEA, you cannot sell first and deal with compliance later. The Product Licence must be in hand before the first sale.

4. Establish a Canadian importer or subsidiary: The Product Licence holder must be a Canadian entity. US brands typically work with a Canadian importer who holds the licence, or establish a Canadian subsidiary.

5. Ensure GMP compliance: Your manufacturing site must meet Health Canada’s NHP GMP requirements and the Canadian importer must hold a Site Licence.

At Care Europe, we advise brands on North American regulatory strategy, including Health Canada NHP compliance for brands entering the Canadian market. Contact us at [email protected].